Jupiter Topco LLC’s Collegium Pharmaceutical COLL Stock Holding History

Jupiter Topco LLC’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.7M	Buy	+2,147,072	New	+$73.4M	0.03%	356

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco LLC's COLL Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 2,147,072 shares worth $77.7M. The stake represents 0.03% of the portfolio and ranks #356 among its holdings.

257 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Jupiter Topco LLC held 2,147,072 shares of Collegium Pharmaceutical worth $77.7M as of Q2 2026.
Collegium Pharmaceutical was a new Jupiter Topco LLC position in Q2 2026.
Collegium Pharmaceutical made up 0.03% of Jupiter Topco LLC's portfolio in Q2 2026, its #356 holding.
257 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.